Cardioprotective Modulation of Cardiac Adiponectin and Adiponectin Receptors by Omega-3 in the High-Fat Fed Rats

10.4077/CJP.2013.BAA069

Sandra M. Younan；Leila A. Rashed；Osama M. Abd El Aziz

adiponectin ； cardiac adiponectin receptors ； omega-3-high fat diet

The Chinese Journal of Physiology

56卷2期（2013 / 04 / 01）

65 - 76

英文

Obesity is an important risk factor for heart disease. This study investigated the effects of omega-3 (ω-3) on reversal of high fat (HF) diet-induced changes in the expression of the cardiac adiponectin and adiponectin receptors R1 and R2. Male rats were fed low-fat (LF; 10% energy from fat) or HF (45% energy from fat) for 16 weeks, LF-ω-3 or a HF-ω-3 (LF or HF for 16 weeks supplemented by ω-3 as 36 g/kg diet for the last 6 weeks, respectively) and a HF diet for 10 weeks to demonstrate HF effect before ω-3 administration. HF diet induced obesity, glucose intolerance, increased heart end systolic and diastolic volumes, decreased serum adiponectin, reduced expression of cardiac and adipose tissue adiponectin and adipo R1 & R2 with elevated serum tumour necrosis factor-α (TNF-α) compared to the LF diet. On the other hand, the HF-ω-3 group compared with the HF group had improved glucose tolerance (area under the glucose curve 837.14 ± 45.7 versus 1158.5 ± 69.8) and insulin resistance with a significant increase in serum adiponectin (4.22 ± 0.39 versus 2.82 ± 0.69 ng/ml) and a significant decrease in serum TNF-α (129.84 ± 13.63 versus 209.8 ± 16.42 pg/ml) and triglycerides independent of obesity. Also the data showed significant increases in the expression of cardiac and adipose tissue adiponectin and adiponectin R1 and adipose tissue adipo R2 as well as cardiac pAMP kinase with improvement in end-systolic and -diastolic volumes. These parameters were also improved compared to initial values in HF-10-week group. In conclusion, dietary ω-3 supplementation has a beneficial effect on fat-induced cardiac dysfunction and insulin resistance partly through increasing adiponectin and adiponectin receptors expression in heart and adipose tissue.

1. Chen, C.Y.,Tsai, Y.L.,Kao, C.L.,Lee, S.D.,Wu, M.C.,Mallikarjuna, K.,Liao, Y.H.,Ivy, J.L.,Kuo, C.H.(2010).Effect of mild intermittent hypoxia on glucose tolerance, muscle morphology and AMPKPGC-1α signaling.Chinese J. Physiol.,53,62-71.
   連結：
2. Barnea, M.,Shamay, A.,Stark, A.H.,Madar, Z.(2006).A High-fat diet has a tissue-specific effect on adiponectin and related enzyme expression.Obesity Res,14,2145-2153.
3. Berg, A.H.,Combs, T.P.,Scherer, P.E.(2002).ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.Trends Endocrinol. Metab.,13,84-89.
4. Bullen, J.W., Jr.,Bluher, S.,Kelesidis, T.,Mantzoros, C.S.(2007).Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice.Am. J. Physiol. Endocrinol. Metab.,292,1079-1086.
5. Chazenbalk, G.,Trivax, B.S.,Yildiz, B.O.,Bertolotto, C.,Mathur, R.,Heneidi, S.,Azziz, R.(2010).Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-α.J. Clin. Endocrinol. Metab.,95,935-942.
6. Chiu, H.C.,Kovacs, A.,Ford, D.A.,Hsu, F.F.,Garcia, R.,Herrero, P.,Saffitz, J.E.,Schaffer, J.E.(2001).A novel mouse model of lipotoxic cardiomyopathy.J. Clin. Invest.,107,813-822.
7. Dandona, P.,Aljada, A.,Bandyopadhyay, A.(2004).Inflammation: the link between insulin resistance, obesity and diabetes.Trends Immunol.,25,4-7.
8. de Mattos, A.B.,Pinto, M.J.,Oliveira, C.,Biz, C.,Ribeiro, E.B.,do Nascimento, C.M.,Andersen, M.L.,Tufik, S.,Oyama, L.M.(2008).Dietary fish oil did not prevent sleep deprived rats from a reduction in adipose tissue adiponectin gene expression.Lipids Health Dis.,7,1-11.
9. de Oliveira, C.,de Mattos, A.,Biz, C.,Oyama, L.,Ribeiro, E.B.,do Nascimento, C.M.(2011).High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations.Lipids Health Dis.,10,11-26.
10. Ding, G.,Qin, Q.,He, N.,Francis-David, S.C.,Hou, J.,Liu, J.,Ricks, E.,Yang, Q.(2007).Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma.J. Mol. Cell. Cardiol.,43,73-84.
11. Duda, M.K.,O''Shea, K.M.,Lei, B.,Barrows, B.R.,Azimzadeh, A.M.,McElfresh, T.E.,Hoit, B.D.,Kop, W.J. ,Stanley, W.C.(2007).Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload.Cardiovasc. Res.,76,303-310.
12. Duda, M.K.,O''shea, K.M.,Tintinu, A.,Xu, W.,Khairallah, R.J.,Barrows, B.R.,Chess, D.J.,Azimzadeh, A.M.,Harris, W.S.,Sharov, V.G.,Sabbah, H.N.,Stanley, W.C.(2009).Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction.Cardiovasc. Res.,81,319-327.
13. Flachs, P.,Mohamed-Ali, V.,Horakova, O.,Rossmeisl, M.,Hosseinzadeh-Attar, M.J.,Hensler, M.,Ruzickova, J.,Kopecky, J.(2006).Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet.Diabetologia,49,394-397.
14. Grundy, S.M.,Cleeman, J.I.,Daniels, S.R.,Donato, K.A.,Eckel, R.H.,Franklin, B.A.,Gordon, D.J.,Krauss, R.M.,Savage, P.J.,Smith, S.C., Jr.,Spertus, J.A.,Fernando, C.(2005).Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.Circulation,112,2735-2752.
15. Inukai, K.,Nakashima, Y.,Watanabe, M.,Takata, N.,Sawa, T.,Kurihara, S.,Awata, T.,Katayama, S.(2005).Regulation of adiponectin receptor gene expression in diabetic mice.Am. J. Physiol. Endocrinol. Metab.,288,E876-E882.
16. Itoh, M.,Suganami, T.,Satoh, N.,Tanimoto-Koyama, K.,Yuan, X.,Tanaka, M.,Kawano, H.,Yano, T.,Aoe, S.,Takeya, M.,Shimatsu, A.,Kuzuya, H.,Kamei, Y.,Ogawa, Y.(2007).Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects.Arterioscler. Thromb. Vasc. Biol,27,1918-1925.
17. Jeyakumar, S.M.,Vajreswari, A.,Giridharan, N.V.(2006).Chronic dietary vitamin A supplementation regulates obesity in an obese mutant WNIN/Ob rat model.Obesity,14,52-59.
18. Jump, D.B.,Botolin, D.,Wang, Y.,Xu, J.,Christian, B.,Demeure, O.(2005).Fatty acid regulation of hepatic gene transcription.J. Nutr.,135,2503-2506.
19. Kalupahana, N.S.,Claycombe, K.,Newman, S.J.,Stewart, T.,Siriwardhana, N.,Matthan, N.,Lichtenstein, A.H. ,Moustaid-Moussa, N.(2010).Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation.J. Nutr.,140,1915-1922.
20. Kewalramani, G.,Puthanveetil, P.,Wang, F.,Kim, M.S.,Deppe, S.,Abrahani, A.,Luciani, D.S.,Johnson, J.D.,Rodrigues, B.(2009).AMP-activated protein kinase confers protection against TNF-α-induced cardiac cell death.Cardiovasc. Res.,84,42-53.
21. Kharroubi, I.,Rasschaert, J.,Eizirik, D.L.,Cnop, M.(2003).Expression of adiponectin receptors in pancreatic β cells.Biochem. Biophys. Res. Commun.,312,1118-1122.
22. Kido, Y.,Burks, D.J.,Withers, D.,Bruning, J.C.,Ronald Kahn, C.,White, M.F.,Accili, D.(2000).Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.J. Clin. Invest.,105,199-205.
23. Kim, A.S.,Miller, E.J.,Young, L.H.(2009).AMP-activated protein kinase: a core signalling pathway in the heart.Acta Physiol. (Oxf),196,37-53.
24. Lord, E.,Ledoux, S.,Murphy, B.D.,Beaudry, D.,Palin, M.F.(2005).Expression of adiponectin and its receptors in swine.J. Anim. Sci.,83,565-578.
25. Mann, D.L.(2002).Tumor necrosis factor-induced signal transduction and left ventricular remodeling.J. Card. Fail.,8,S379-S386.
26. Mantzioris, E.,Cleland, L.G.,Gibson, R.A.,Neumann, M.A.,Demasi, M.,James, M.J.(2000).Biochemical effects of a diet containing foods enriched with n-3 fatty acids.Am. J. Clin. Nutr.,72,42-48.
27. Matsubara, M.,Maruoka, S.,Katayose, S.(2002).Decreased plasma adiponectin concentrations in women with dyslipidemia.J. Clin. Endocrinol. Metab.,87,2764-2769.
28. Mazumder, P.K.,O''Neill, B.T.,Roberts, M.W.,Buchanan, J.,Yun, U.J.,Cooksey, R.C.,Boudina, S.,Abel, E.D.(2004).Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.Diabetes,53,2366-2374.
29. Mehra, M.R.,Lavie, C.J.,Ventura, H.O.,Milani, R.V.(2006).Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure.J. Heart Lung Transplant.,25,834-838.
30. Mozaffarian, D.(2008).Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death.Am. J. Clin. Nutr.,87,1991S-1996S.
31. Neschen, S.,Morino, K.,Rossbacher, J.C.,Pongratz, R.L.,Cline, G.W.,Sono, S.,Gillum, M.,Shulman, G.I.(2006).Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-γ-dependent mechanism in mice.Diabetes,55,924-928.
32. Nishimura, M.,Ajiro, K.,Sawamura, M.,Ikeda, K.,Nara, Y.,Seino, Y.,Yamori, Y.(2000).Beneficial effects of fish oil on glucose metabolism in spontaneously hypertensive rats.Clin. Exp. Pharmacol. Physiol.,27,412-425.
33. Olivares, E.L.,Ribeiro, V.P.,Werneck de Castro, J.P.S.,Ribeiro, K.C.,Mattos, E.C.,Goldenberg, R.C.S.,Mill, J.G.,Dohmann, H.F.,Ribeiro dos Santos, R.,Campos de Carvalho, A.C.,Masuda, M.O.(2004).Bone marrow stromal cells improve cardiac performance in healed infarcted rat hearts.Am. J. Physiol. Heart Circ. Physiol,287,H464-H470.
34. Ouchi, N.,Kihara, S.,Arita, Y.,Okamoto, Y.,Maeda, K.,Kuriyama, H.,Hotta, K.,Nishida, M.,Takahashi, M.,Muraguchi, M.,Ohmoto, Y.,Nakamura, T.,Yamashita, S.,Funahashi, T.,Matsuzawa, Y.(2000).Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway.Circulation,102,1296-1301.
35. Psota, T.L.,Gebauer, S.K.,Kris-Etherton, P.(2006).Dietary omega-3 fatty acid intake and cardiovascular risk.Am. J. Cardiol.,98,I3-18.
36. Ren, L.Q.,Hu, D.B.,Li, Y.J.,Sheng, Z.L.,Li, Y.Z.(2010).Regulatory effects of rosiglitazone on cardiac adiponectin system in hyperlipidemic rats.Chinese J. New Drugs Clin. Remedies,2010(03)
37. Rossmeisl, M.,Jelenik, T.,Jilkova, Z.,Slamova, K.,Kus, V.,Hensler, M.,Medrikova, D.,Povysil, C.,Flachs, P.,Mohamed-Ali, V.,Bryhn, M.,Berge, K.,Holmeide, A.K.,Kopecky, J.(2009).Prevention and reversal of obesity and glucose intolerance in mice by DHA derivatives.Obesity,17,1023-1031.
38. Saito, Y.,Fujioka, D.,Kawabata, K.I.,Kobayashi, T.,Yano, T.,Nakamura, T.,Kodama, Y.,Takano, H.,Kitta, Y.,Obata, J.E.,Kugiyama, K.(2007).Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-α-treated cardiomyocytes in association with improved glucose uptake.Am. J. Physiol. Heart Circ. Physiol.,293,H3490-H3497.
39. Shah, K.B.,Duda, M.K.,O''shea, K.M.,Sparagna, G.C.,Chess, D.J.,Khairallah, R.J.,Robillard-Frayne, I.,Xu, W.,Murphy, R.C.,Des Rosiers, C.,Stanley, W.C.(2009).The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: role of cardiac phospholipid remodeling.Hypertension,54,605-611.
40. Sharma, N.,Okere, I.C.,Duda, M.K.,Chess, D.J.,O''Shea, K.M.,Stanley, W.C.(2007).Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.Cardiovasc. Res.,73,257-268.
41. Thulé, P.M.,Campbell, A.G.,Kleinhenz, D.J.,Olson, D.E.,Boutwell, J.J.,Sutliff, R.L.,Michael Hart, C.(2006).Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats.Am. J. Physiol. Endocrinol. Metab.,290,E114-E122.
42. Tilg, H.,Moschen, A.R.(2006).Adipocytokines: mediators linking adipose tissue, inflammation and immunity.Nat. Rev. Immunol.,6,772-783.
43. Tsuchida, A.,Yamauchi, T.,Ito, Y.,Hada, Y.,Maki, T.,Takekawa, S.,Kamon, J.,Kobayashi, M.,Suzuki, R.,Hara, K.,Kubota, N.,Terauchi, Y.,Froguel, P.,Nakae, J.,Kasuga, M.,Accili, D.,Tobe, K.,Ueki, K.,Nagai, R.,Kadowaki, T.(2004).Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity.J. Biol. Chem.,279,30817-30822.
44. Valen, G.,Yan, Z.Q.,Hansson, G.K.(2001).Nuclear factor κ-B and the heart.J. Am. Coll. Cardiol.,38,307-314.
45. Yamauchi, T.,Kamon, J.,Ito, Y.,Tsuchida, A.,Yokomizo, T.,Kita, S.,Sugiyama, T.,Miyagishi, M.,Hara, K.,Tsunoda, M.,Murakami, K.,Ohteki, T.,Uchida, S.,Takekawa, S.,Waki, H.,Tsuno, N.H.,Shibata, Y.,Terauchi, Y.,Froguel, P.,Tobe, K.,Koyasu, S.,Taira, K.,Kitamura, T.,Shimizu, T.,Nagai, R.,Kadowaki, T.(2003).Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.Nature,423,762-769.
46. Yamauchi, T.,Kamon, J.,Waki, H.,Terauchi, Y.,Kubota, N.,Hara, K.,Mori, Y.,Ide, T.,Murakami, K.,Tsuboyama-Kasaoka, N.,Ezaki, O.,Akanuma, Y.,Gavrilova, O.,Vinson, C.,Reitman, M.L.,Kagechika, H.,Shudo, K.,Yoda, M.,Nakano, Y.,Tobe, K.,Nagai, R.,Kimura, S.,Tomita, M.,Froguel, P.,Kadowaki, T.(2001).The fatderived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.Nat. Med.,7,941-946.